Whole‐genome sequencing identifies EN1 as a determinant of bone density and fracture

Hou‐Feng Zheng, Vincenzo Forgetta, Yi‐Hsiang Hsu, +78

Nature

Bone DiseaseBone HealthFracture DiagnosticsGeneticsBone Remodeling +8

Metabolomic Patterns in Glioblastoma and Changes during Radiotherapy: A Clinical Microdialysis Study

Carl Wibom, Izabella Surowiec, Lina Mörén, +4

Journal of Proteome Research

Conventional Radiotherapy TreatmentMetabolomic ProfilingMetabolic RemodelingHigh-grade GliomasGlioma +20

Distinct metabolic hallmarks of WHO classified adult glioma subtypes

Benny Björkblom, Carl Wibom, Maria Eriksson, +7

Neuro-Oncology

Synergistic killing of glioblastoma stem-like cells by bortezomib and HDAC inhibitors.

Thomas Asklund, Samuel Kvarnbrink, Camilla Holmlund, +4

PubMed

Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism

Nitesh Mistry, Carl Wibom, Magnus Evander

Virology Journal

Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk

Benny Björkblom, Carl Wibom, Pär Jonsson, +6

Oncotarget

Glioblastoma RiskMetabolomic ProfilingPathologyHigh-grade GliomasRadiation Biology +20

Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas

Lina Mörén, Carl Wibom, Per Bergström, +3

Radiation Oncology

Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma

Soma Ghasimi, Carl Wibom, Anna M. Dahlin, +4

Journal of Neuro-Oncology

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome

Stefan Sjöström, Carl Wibom, Ulrika Andersson, +8

Journal of Neuro-Oncology

GeneticsGenetic EpidemiologyHuman PolymorphismPathologyVegfr2 Polymorphisms +15

CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma

Anna M. Dahlin, Mads V. Hollegaard, Carl Wibom, +5

Journal of Neuro-Oncology